Govt. Hospital of Thoracic Medicine,
Tambaram Sanatorium, Chennai
PUBLISHED WORKS OF GHTM, TAMBARAM- 1949-2008
1.
Vasudeva Rao K. Rehabilitation of tuberculosis ex-patients. Tuberculosis
Workers Conference, 7th, Bombay, India, 23-25 Nov 1949, p. 196-204.
2.
Rao KN, Thoracoplasty
with Modified Hoist’s Technique. The Indian journal of Tuberculosis,
1954, 1, 99-104.
3.
Krishnaswamy; K.V., Proceedings
24th National Cong. Tubercle
& Chest Dis., Trivandrum, 1969, P. 254
4.
Rangaswamy
V, Janakavalli. Detection of pulmonary Nocardiosis among suspected
cases of pulmonary tuberculosis. Indian J Chest Dis. 1971,
13(3):85-92.
5.
Rangaswamy V, Srinivasan V, Janakavalli.
Aspergillus infection in tubular cavities. Indian J Chest Dis. 1972,
14(2):55-60.
6.
Krishnaswami
KV and Seshagiri, K. Intermittent chemotherapy in Pulmonary Tuberculosis with
Ethambutol and Isoniazid, Ind. J. of Chest Dis. 1973; 15, 1, 1-8.
7.
Krishnaswami KV,
Analysis of child patients admitted to TB Sanatorium, Tambaram, over a period of
5 years, Ind. J. Tub, 1973, 20, 147-50.
8.
Rangaswamy
V, Kumari RV, Seshagiri K. Serological diagnosis of pulmonary
aspergillosis. Indian J Pathol Microbiol. 1977 Apr; 20(2):
101-4.
9.
Sundaram S, Kalyanasundaram R and Rangaswamy V. Serological
diagnosis of pulmonary aspergillosis. Mycopathologia,
1981,
75, 93-99.
10.
Rangaswamy
V; Jagannathan K; Natarajan AS. Rifampicin
and Ethambutol intermittent therapy in the Retreatment of failure cases. Lung
India. 1982 Aug; 1(1): 29-31.
11.
Jagannath K, Rajasekaran S, Vasanthakumari R. Short-course chemotherapy
of pulmonary tuberculosis under programme conditions. Proceedings of XIV Eastern
regional Tuberculosis Conference of IUAT, Kathmandu, Nepal, November 1985, Pp
47.
12.
Vasanthakumari R, Jagannath K.
Rajasekaran S. Use of transport medium for culturing tubercle bacilli: (a
modified technique). Lung
India. 1985 May; 3(2): 73-6.
13.
Jagannath K, Rajasekaran S, Vasanthakumari R. Short-course chemotherapy
of pulmonary tuberculosis and its applicability in field conditions. Indian
Journal of Tuberculosis. 1985 Apr; 32(2): 91-5.
14.
Rajasekaran
S, Jagannath K, Vasanthakumari R, Devasenapathi, Khaiser Ahamed PR, Jayaseeli K.
Fate of treatment defaulters: a bacteriological assessment.
Indian Journal of Tuberculosis,
1986, 33, 90.
15.
Vasanthakumari R,
Jagannath K,
Rajasekaran S.
A cold staining
method for acid-fast bacilli. Bull
World Health Organ. 1986; 64(5):741-3.
16.
Rajasekaran S, Paramasivan R, Jayaseeli,
Seshagiri K.. Management
of primary treatment failures under TB control programme, Indian
Journal of Tuberculosis,
1987, 34, 64.
17.
Vasanthakumari R,
Jagannath K,
Rajasekaran S.
Cold staining
for Acid Fast Bacilli. Indian
Journal of Tuberculosis,
1987, 34, 64.
18.
Vasanthakumari R; Jagannath K; Rajasekaran. The
effect of storage on tubercle bacilli in a transport medium and a simplified
culture technique. Indian Journal of Tuberculosis.
1987 July; 34(3): 143-6.
19.
Rajasekaran S; Parmasivan R; Sujathakumari; Palanisami S. The value of
Pyrazinamide in second phase of short course chemotherapy of pulmonary
tuberculosis: an assessment. Indian Journal of Tuberculosis.
1988 Apr; 35(2): 76-9.
20.
Parmasivan
R, Rajasekaran S, Selvaraj D. Strategies in effective utilisation of
tuberculosis hospital beds, Indian
Journal of Tuberculosis,
1989, 36, 72.
21.
Rajasekaran
S; Paramasivan R; Palanisami S; Sujathakumari PL. Prediction of relapse in tuberculosis. Lung
India. 1989 Aug; 7(3): 113-7.
22.
Rajasekaran
S; Paramasivan R; Sujathakumari; Palanisami S; Parthasarathy RT. Sensitivity
of tuberculin test. Lung
India. 1991 Nov; 9(4): 130-1.
23.
Rajasekaran S; Parmasivan R; Sujathakumari PL; Palanisami S. Six-month
non-Isoniazid Retreatment for pulmonary tuberculosis patients with primary
treatment failure. Lung
India. 1991 Aug; 9(3): 99-103.
24.
Rajasekaran S; Paramasivan R; Sujathakumari PL; Palanisami S. Effective
short course chemotherapy for pulmonary tuberculosis under field conditions. Lung
India. 1991 May; 9(2): 52-6.
25.
Rajasekaran S; Paramasivan R; Venkatesan R. Efficacy of medical salvage
in chronic pulmonary tuberculosis patients. Lung
India. 1991 Feb; 9(1): 11-5.
26.
Rajasekaran S; Paramasivan R. Bacteriological pointers to management of
treatment defaulting pulmonary tuberculosis patients. Lung
India. 1992 Nov; 10(4): 149-52.
27.
Paramasivan R; Rajasekaran S; Selvaraj D. Evolution of admission policy
in a tuberculosis hospital: suggested model. Lung
India. 1992 Aug; 10(3): 110-4.
28.
Bhatia
RS, Deivanayagam CN. HIV Disease-
The great waster upon us. Lung India, 1992, 10, 91-93.
29.
Paramasivan R; Parthasarathy RT; Rajasekaran S. Short course
chemotherapy: a controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis.
1993 Oct; 40(4): 185-90.
30.
Nageswari AD, Parmasivam R, Chellammal, Kesolon J. Socio-behavioral study
of HIV & Tuberculosis. Indian
Journal of Tuberculosis, 1993, 40, 164
31.
Deivanayagam CN, Superintendent, Government Hospital of Thoracic Medicine,
Tambaram Sanatorium, Madras-600 047 Financing and restructuring health care in
India [editorial]. Lung India. 1994 Nov;
12(4): 163-7.
32.
Suguna K; Santhanakrishnan M; Deivanayagam CN Government Hospital of
Thoracic Medicine, Tambaram, Madras-600 047 Azelastine in atopic bronchial
asthma: a comparison with ketotifen. Lung India. 1994 May;
12(2): 77-80.
33.
Rajasekaran S. Pulmonary tuberculosis and blood groups [correspondence]. Lung
India. 1994 Nov; 12(4): 161.
34.
Paramasivan
R; Rajasekaran S; Parthasarathy RT. Haemoptysis
and pulmonary tuberculosis: an analysis. Lung
India. 1994 Nov; 12(4): 192-4.
35.
Paramasivan R; Rajasekaran S; Gopalasamy M; Palanisami S. Short course
chemotherapy for childhood tuberculosis: Standardisation of drug dosages. Lung
India. 1994 Aug; 12(3): 135-7.
36.
Gaude GS; Deivanayagam CN. Tuberculosis risk for health care workers is
real: what can be done now? [Editorial]. Lung India. 1995 Aug &
Nov; 13(3&4): 91-6.
37.
Deivanayagam
CN. Antibiotic therapy in tuberculin-positive children with lung
lesions. Natl Med J India. 1996, Mar-Apr;9(2):99.
38. Kalpana S, Jeyakar paul, Deivanayagam C N, Raja D, Samuel N M. Prevalence of HIV-2 Infection in South India. First International Conference on AIDS INDIA 2000, 1997.
39.
Viswanath
R, Deivanayagam C N, Sankaran J R, Samuel N M. Enumeration of CD4/CD8 cell
counts in patients with HIV/AIDS, HIV /STD, HIV/TB in Tamilnadu. First International Conference on AIDS INDIA 2000,
1997.
40.
Deivanayagam CN. Cor pulmonale-what the clinician should do? [editorial] Lung
India. 1998 July-Sep; 16(3): 101-3.
41.
Deivanayagam CN, Traditional Medicine: Siddha therapy in HIV Disease –
a South Indian Experience. World AIDS Conference, Durban, 2000.
42.
Shobha JC, Ramesh Kumar T, Deivanayagam CN, Raj B Singh, Pradyut Waghray,
Aravinda Babu P, Jaydip Bhaduri, Chandrasekhar C. Clinical Evaluation of the
Tolerability and Efficacy of Trovafloxacin compared with Sparfloxacin in the
treatment of Lower Respiratory Tract Infections. Clin Drug Invest. 2000, 20(2),
95-100.
43.
Saravanakumar
D', Elangeswaran N, Senthilkumar
TM, Vanaja G, Kamakshiamma S, Chandrasekar C, Deivanayagam CN, Manjula Sritharan
and. Sritharan V. Isolation,
PCR based identification, and sensitivity pattern of Environmental Mycobacteria
from leprosy and tuberculosis Patients. Indian
Journal of Clinical Biochemistry (2000), 15(2), 94-103.
44.
R, PR, R,
M, . Reduced NK activity
in pulmonary tuberculosis patients with/without HIV infection: identifying the
defective stage and studying the effect of interleukins on NK activity.
Tuberculosis, 2001
81, 343-352.
45.
C N Deivanayagam,O R Krishnarajasekhar,
N Ravichandran.
Evaluation of Siddha Medicare in HIV disease.
J Assoc Physicians India. 2001 Mar; 49: 390-1.
46.
Deivanayagam CN; Rajasekaran S; Senthilnathan V; Krishnarajasekhar OR;
Raja K; Chandrasekar C; Palanisami S; Dinesh AS; Jothivel G and Elango SV.
Clinico-radiological spectrum of tuberculosis among HIV sero-positives: a
Tambaram study. Indian
Journal of Tuberculosis. 2001 Jul; 48(3): 123-27.
47.
Ranjani
Ramachandran, Soumya Swaminathan, Sulochana Somasundaram, Asgar VN, Paramesh P5
and Paramasivan CN. Mycobacteremia in tuberculosis patients with HIV infection. Ind
J Tub, 2002, 50, 29 - 31.
48.
Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Khaiser Ahmed
PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R.
Prevalence of acquired MDR-TB and HIV co-infection. Indian
Journal of Chest Diseases and Allied Sciences. 2002 Oct-Dec; 44(4):
237-42.
49.
Swaminathan S; Sangeetha M; Arunkumar N; Menon PA; Thomas B; Shibi K;
Ponnuraja; Rajasekaran S. Pulmonary tuberculosis in HIV positive individuals :
preliminary report on clinical features and response to treatment ; Indian
Journal of Tuberculosis. 2002 Oct; 49(4): 189-93
50.
Selvakumar N, Rahman F, Garg R, Rajasekaran S, Mohan NS, Thyagarajan K, Sundaram V, Santha T, Frieden TR, Narayanan PR. Evaluation of the phenol ammonium sulfate sedimentation smear microscopy
method for diagnosis of pulmonary tuberculosis. J
Clin Microbiol. 2002 Aug; 40(8):3017-20.
51.
Williams, Thiruvalluvan M, Paramesh P, Rajasekaran S, Krishnarajasekar OR. HIV
and HTLV I Co infection. Indian
Medical Gazette, 2002, CXXXVI, 123-126.
52.
Rahman F, Rajasekaran S, Narayanan PR, Frieden TR. Inefficiency of 0.3% carbol fuchsin in Ziehl-Neelsen staining for
detecting acid-fast bacilli. J
Clin Microbiol. 2002 Aug;40(8):3041-3.
53.
Gupta
RN, Wyatt GE, Swaminathan S, Venkatesan P, Rewari BB, Deivanayagam CN,
Rajasekaran S, Mishra RS, Dhir VK, Ranganath V. Psychosexual
Health and Risk Factors for HIV among Married Indian Women. Conf
Retroviruses Opportunistic Infect 2003 Feb 10-14; 10th: abstract no. 931.
54.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Priyadarshini P,
Swaminathan S, Venkatesan P, Sekar
L and Rajasekaran S. Absorption of
Rifampicin and Isoniazid in HIV infected patients with and without tuberculosis.
IAS Conf HIV Pathog Treat 2003 Jul 13-16; 2nd: Abstract No. 875; Antiviral
Therapy 2003; 8(Suppl. 1):S431.
55.
Srihari BJ, Jacob M,
Rajasekaran S, Bhirmanandham CV and Samuel NM,
Correlation of CD4T cells
with total lymphocyte counts (TLC) – a marker for monitoring HIV/AIDS patients
in resource limited settings. IAS Conf HIV Pathog Treat 2003 Jul 13-16;2nd:
Abstract No. 477 Antiviral Therapy 2003; 8(Suppl. 1):S310.
56.
Rajasekaran S, Jeyaseelan L, Paramesh P, Loo V, Warren D. HIV/AIDS care
in government hospital for thoracic medicine at Tambaram: A family-level
approach. Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. MoPeC3554.
57.
Paramesh P, Loo V, Rajasekaran S, Kumar S, Warren D. Improvements in
patient management attributed to the design of an electronic medical record-
Tambaram, India. Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. E12526.
58.
Rajasekaran S, Loo V, Paramesh P, Jeyaseelan L, Warren D. Health care
seeking behavior among HIV-infected women in Tamilnadu, India. Int Conf AIDS.
2004 Jul 11-16; 15: abstract no. C12063.
59.
Swaminathan S, Rajasekar S, Ponnuraja C, Sujatha N,
Paramasivan CN, Hanna LE, Narayanan PR. Recurrent Tuberculosis and Mortality Are High in Patients with
Advanced HIV Disease Treated with Short-course Chemotherapy.11th Conf Retrovir
Opportunistic Infect Febr 8 11 2004 San Franc CA Conf Retrovir Opportunistic
Infect 11th 2004 San Franc Calif. 2004 Feb 8-11; 11: abstract no. 764.
61.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Venkatesan P, Sekar L, Kumar S, Krishnarajasekhar OR, Paramesh P. Clin
Infect Dis. Malabsorption of
Rifampin and Isoniazid in HIV-infected patients with and without tuberculosis. Clin
Infect Dis. 2004 Jan 15;38(2):280-3.
62.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N, Paramesh P. Decreased bioavailability of Rifampin and other antituberculosis drugs in
patients with advanced human immunodeficiency virus disease. Antimicrob
Agents Chemother. 2004 Nov; 48(11):4473-5.
63.
Swaminathan S, Rajasekaran S, Shibichakravarthy K, Amarendran VA, Raja K, Hari L, Narayanan S. Multiple recurrences of tuberculosis in an HIV infected individual. J
Assoc Physicians India. 2004 Jun; 52:513-4. (Correspondence).
64.
Thomas,
B.E., Suryanarayanan, D., Muniyandi, M., Meenalochani, D., Rajasekaran, S. and
Swaminathan, S. Is awareness of HIV enough to alter high-risk behaviour? What do
HIV positive individuals have to say? A study from South India. SAARC J Tuberc
Lung Dis HIV/AIDS 2 (2005) 1.
65.
Suhadev M; Swaminathan S; Rajasekaran S; Thomas BE; Arun Kumar N;
Muniyandi M; Meenalochani D. Feasibility of Community DOT providers for
tuberculosis treatment in HIV infected individuals- A pilot study. Indian Journal of Tuberculosis.
2005 Oct; 52(4): 179-83.
66.
Ramachandran, G., Hemanth Kumar, A.K., Rajasekaran, S., Padmapriyadarsini,
C., Swaminathan, S., Venkatesan, P., Sekar, L. and Gurumurthy, P. Acetylator
status influences bioavailability of Isoniazid in patients with advanced HIV
disease. SAARC J Tuberc Lung Dis HIV/AIDS 2 (2005) 9.
67.
Ramachandran, G., Hemant Kumar, A.K., Gurumurthy, P., Rajasekaran, S.,
Chandrasekaran, P., Bhagavathy, S., Venkatesan, P., sekar, L. and swaminathan,
S. Effect of HIV on pharmacokinetics of anti tuberculosis drugs. Contagion 2
(2005) 2.
68.
Soumya Swaminathan, S Iliayas, C Padmapriyadarsini, S Rajasekaran, V
Mohan, C Ponnuraja, P Venkatesan, R Ramachandran, C Paramasivan, S Ramesh Kumar,
P Menon, M Dilip, and P Narayanan. Randomized clinical
trial of 6-month versus 9-month anti-tuberculosis treatment in HIV+ individuals
with pulmonary tuberculosis. Conf Retrovir Opportunistic Infect 2005
Feb 22-25; 12: abstract no. 141.
69.
Ramachandran G., Hemanth Kumar A.K., Rajasekaran S., Padmapriyadarsini
C., Narendran G., Sukumar B., Swaminathan S. Increasing
Nevirapine dose can overcome reduced bioavailability due to Rifampicin
co-administration. IAS
Conf HIV Pathog Treat 2005 Jul 24-27; 3rd: Abstract No. WePe3.3C02.
70.
Rajasekaran
S, Paramesh P, Jeyaseelan L, Annadurai S, Bellah and Vijila. Linking TB and HIV programmes: A simple score
based diagnostic tool for DOTS Centres. Indian Journal of Tuberculosis, 2005,
52, 158
71.
Swaminathan S,
Paramasivan CN,
Ponnuraja C,
Iliayas S,
Rajasekaran S,
Narayanan PR.
Anti-tuberculosis
drug resistance in patients with HIV and tuberculosis in South India. Int
J Tuberc Lung Dis. 2005 Aug; 9(8):896-900.
72.
Shankar EM, Rajasekaran S, Rao UA, Paramesh P, Krishnakumar R, Rajan R, Kownhar H. Colonization of Mycoplasma in the upper respiratory tract of AIDS patients
with pulmonary symptoms in Chennai, India. . Indian
J Med Res. 2005 Dec; 122(6):506-10.
73.
Vaidya S.B., Ramchandani S.R., Saple D.G., Mehta S.H., Pandey V.P.,
Vadrevu R., Rajasekaran S., Bhatia V.P. Chowdhary A., Bollinger R.C., Gupta A. Knowledge,
attitudes, and practices of HIV care and antiretroviral therapy among
HIV-infected adults attending private and public clinics in India. Int
Conf AIDS. 2006 Aug 13-18;16
Abstract No. ThAb0204
74.
Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN. Plant-based formulation in the management of chronic obstructive pulmonary
disease: a randomized double-blind study. Respir
Med. 2006 Jan; 100(1):39-45.
75.
Murali PM, Rajasekaran S, Krishnarajasekar OR, Perumal T, Nalini K, Lakshmisubramanian S, Deivanayagam CN. Plant-based formulation for bronchial asthma: a controlled clinical trial
to compare its efficacy with oral salbutamol and theophylline. Respiration.
2006;73(4):457-63.
76.
Rajasekaran
S, Vijila S, Ravichandran N. Immune Reconstitution Tuberculosis in HIV Patients
after Antiretroviral Therapy. JK Science, 2006,
8, 205-7.
77.
Ramachandran G, Hemanthkumar AK, Rajasekaran S, Padmapriyadarsini C, Narendran G, Sukumar B, Sathishnarayan S, Raja K, Kumaraswami V, Swaminathan S. Increasing Nevirapine dose can overcome reduced bioavailability due to
rifampicin co administration. J
Acquir Immune Defic Syndr. 2006 May; 42(1):36-41.
78.
Narendran G, Swaminathan S, Sathish S, Rajasekaran S. Immune reconstitution syndrome in a child with TB and HIV. Indian
J Pediatr. 2006 Jul; 73(7):627-9.
79.
Kumar CP, Menon T, Sundararajan T, Nalini S, Thirunarayan MA, Rajasekaran S, Venkatadesikalu M. Esterase activity of Candida species isolated from immunocompromised
hosts.Rev
Iberoam Micol. 2006 Jun; 23(2):101-3.
80.
Dorairajan Sureshkumar and Sigamani Rajasekaran. Depression
in persons living with HIV/AIDS: a report. HIV Med 2007; 8(Suppl. 1):32
(abstract no. P93).
81.
Influence
of CYP2B6 Polymorphism on Plasma Concentrations of Efavirenz and Nevirapine in
HIV-infected Patients in South India. Conf Retrovir Opportunistic Infect 2007; 98:
abstract no. 554.
82.
Kumar
CPG, Menon T, Rohini PS, Rajasekaran S, Sundararajan T and Venkatadesikalu M. Anti-Candida
antibodies and candidemia in ninety patients with HIV/AIDS and cancer. Journal de Mycologie Médicale / Journal of Medical Mycology,
2007,
17, 50-53.
83.
Rajasekaran S, Murugesan K, Mahilmaran A, Krishnarajasekhar OR, Kumar S,
Annadurai S and Khaiser Ahamed PR. Linking
of TB & HIV Programmes: Outcome of referral system: A Tamilnadu experience.
Indian Journal of Tuberculosis, 2007, 53, 169-70.
84.
Rajasekaran S, Annadurai S, Rabeetha, Mahesh, Mahilmaran A, Kumar S, and
Raja K. Manifestation of Tuberculosis in HIV patients - A large Indian Study.
Indian Journal of Tuberculosis, 2007, 53, 169.
85.
Rajasekaran S, Satish Narayan, Vijila and Ravichandran N. Immune
Reconstitution Tuberculosis in HIV patients after Anti-retroviral Therapy.
Indian Journal of Tuberculosis, 2007, 53, 169.
86.
Raiasekaran S, Khaiser Ahamed PR, Mahilmaran A, Krishnarajasekhar OR,
Kumar S, Dravidaselvanayagi and Mala. MDR –TB: Treatment Outcome. Indian
Journal of Tuberculosis, 2007, 53, 166.
87.
Rajasekaran
S, Gomathi, Rabeetha, Mahilmaran A,
Raja K. Role
of Chemoprophylaxis in preventing immune-reconstitution Tuberculosis in HIV
patients on Antiretroviral Therapy. Indian Journal of Tuberculosis, 2007, 54,
209.
88.
Rajasekaran S, Vijila, Devanand, Kumar S and Chandrasekar C. Efficacy of
DOTS (Anti-TB Treatment) in HIVTB Patients on Anti-Retroviral Therapy. Indian
Journal of Tuberculosis, 2007,54, 209
89.
Hemanth Kumar AK, Geetha Ramachandran, Rajasekaran S, Padmapriyadarshini
C, Narendran G, Pradeep Menon, Narayanan PR and Soumya Swaminathan.
Pharmacokinetics of Rifampicin during antiretroviraltreatment. Indian Journal of
Tuberculosis, 2007, 54, 207.
90.
Swaminathan S, Padmapriyadarsini C, Ponnuraja C, Sumathi CH, Rajasekaran S, Amerandran VA, Reddy M, Deivanayagam CN.J
Miliary tuberculosis in human
immunodeficiency virus infected patients not on antiretroviral therapy: Clinical
profile and response to short course chemotherapy. Postgrad Med.
2007 Oct-Dec; 53(4):228-31.
91.
Ramchandani SR, Mehta SH, Saple DG, Vaidya SB, Pandey VP, Vadrevu R, Rajasekaran S, Bhatia V, Chowdhary A, Bollinger RC, Gupta A. Knowledge, attitudes, and practices of antiretroviral therapy among
HIV-infected adults attending private and public clinics in India. AIDS
Patient Care STDS. 2007 Feb; 21(2):129-42.
92.
Hemanth Kumar AK, Ramachandran G, Kumar P, Anitha S, Rajasekaran S, Swaminathan S. Effect of anticoagulants on plasma Nevirapine and Efavirenz
concentrations. Ther
Drug Monit. 2007 Oct; 29(5): 652-4.
93.
Sikhamani Rajasekaran, Jeyaseelan L, Patrick Nadol, Meade Morgan, Dora
Warren, Michael Friedman, Chandrasekar C, Supriya Sahu. Scaling
up ART Services at the Government Hospital of Thoracic Medicine, Tambaram,
India. Presented at PEPFAR HIV Implementers Conference
on June 18, 2007 at Kigali, Rwanda, Africa; poster 160.
94.
Tom Furtwangler, Sikhamani Rajasekaran, Vijay Anthony Prabhu, Michele
Clark, Gurusamy Manoharan. Filming
Real HIV Patient Cases in India. Global Health Council, Washington,
DC, May 29-June 1 2007.
95.
Rajasekaran,
L. Jeyaseelan, A. Mahilmaran, O.R. Krishnarajasekhar,
S. Kumar, S. Annadurai.
A diagnostic tool to screen for HIV co-infection at the TB DOTS centre in India.
SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, 2007, 4, 1-7.
96.
Rajasekaran S; Mahilmaran A; Annadurai S; Kumar S; Raja K. Manifestation
of tuberculosis in patients with human immunodeficiency virus: A large Indian
study. Annals
of Thoracic Medicine, 2007, 58-60.
97.
Rajasekaran S,
Jeyaseelan L,
Vijila S,
Gomathi C,
Raja K.
Predictors of
failure of first-line antiretroviral therapy in HIV-infected adults: Indian
experience. AIDS. 2007 Jul; 21 Suppl
4:S47-53.
98.
Geetha
Ramachandran, A.K. Hemanthkumar, S. Rajasekaran, Padmapriyadarsini C, Narendran
G, Anitha S, Sudha Subramanyam, Kumaraswami V, Soumya Swaminathan.
Steady-State Pharmacokinetics of
Nevirapine in HIV-1 Infected Adults in India. Journal
of the International Association of Physicians in AIDS Care (JIAPAC), 2007,
6(4), 251-254).
99.
Siddharth
Bakshi, Geetha
Ramachandran, Karunaianandham
Ramesh, Agibothu
K Hemanthkumar, Suresh
Anitha, Chandrasekaran
Padmapriyadarsini, Gopalan
Narendran, Pradeep
A Menon, Sikhamani
Rajasekaran, Soumya
Swaminathan. Study of ABCB1 polymorphism (C3435T) in HIV-1-infected
individuals from South India. Br J Clin Pharmacol. 2008 Jan 30;
18241284.
100.
Girish Kumar CP, Menon T, Rajasekaran S, Sekar B, Prabu D.
Carriage of Candida species in oral cavities of HIV infected patients in
South India. Mycoses.
2008 Jun 3.
101.
Soumya Swaminathan, Deivanayagam CN, Rajasekaran S, Venkatesan P,
Padmapriyadarsini C, Pradeep A Menon, Ponnuraja C, Meenalochani Dilip. Long term
follow up of HIV-infected patients with tuberculosis treated with 6-month
intermittent short course chemotherapy. Natl Med J India, 2008, 21, 3–8
102.
Rajasekaran S, Jeyaseelan L, Raja K, Ravichandran N. Demographic and
Clinical Profile of HIV Infected Children Accessing Care at
Tambaram, India. Indian Journal of Medical Research, in
press.
103.
Rajasekaran S, Jeyaseelan L, Ravichandran N, Gomathi C,
Francis Thara and Chandrasekar C. Efficacy
of Antiretroviral Therapy Program in Children in India: Prognostic Factors and
Survival Analysis. Journal of Tropical Pediatrics Advance
Access published online on June 3, 2008.